Walleye Capital’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4M Buy
+386,183
New +$11.8M 0.05% 344
2026
Q1
Sell
-42,976
Closed -$1.49M 4659
2025
Q4
$1.49M Sell
42,976
-37,948
-47% -$1.21M ﹤0.01% 2110
2025
Q3
$2.2M Buy
80,924
+62,989
+351% +$1.52M 0.01% 1497
2025
Q2
$377K Sell
17,935
-39,706
-69% -$762K ﹤0.01% 2878
2025
Q1
$944K Buy
57,641
+36,329
+170% +$774K ﹤0.01% 2018
2024
Q4
$548K Sell
21,312
-119,859
-85% -$3.39M ﹤0.01% 2907
2024
Q3
$4.47M Buy
141,171
+127,800
+956% +$4.85M 0.01% 1254
2024
Q2
$469K Sell
13,371
-100,666
-88% -$3.99M ﹤0.01% 3565
2024
Q1
$5M Sell
114,037
-85,854
-43% -$3.69M 0.01% 1296
2023
Q4
$7.11M Buy
199,891
+115,928
+138% +$3.46M 0.02% 874
2023
Q3
$2.27M Buy
+83,963
New +$2.13M 0.01% 1632

Other funds holding IDYA

Walleye Capital's IDYA Position: Q2 2026 in Review

Walleye Capital opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 386,183 shares worth $14.4M. The stake represents 0.05% of the portfolio and ranks #344 among its holdings. This is a return to the name: Walleye Capital previously reported a position in IDYA as recently as Q4 2025.

Walleye Capital first reported a position in IDYA in Q3 2023 and has held it in 11 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Walleye Capital held 386,183 shares of IDEAYA Biosciences worth $14.4M as of Q2 2026.
  • IDEAYA Biosciences was a new Walleye Capital position in Q2 2026.
  • IDEAYA Biosciences made up 0.05% of Walleye Capital's portfolio in Q2 2026, its #344 holding.
  • Walleye Capital first reported a position in IDEAYA Biosciences in Q3 2023 and has held it in 11 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.